The University of Southampton
University of Southampton Institutional Repository

The mechanism of adenosine 5'-monophosphate (AMP)-induced bronchoconstriction in asthma

The mechanism of adenosine 5'-monophosphate (AMP)-induced bronchoconstriction in asthma
The mechanism of adenosine 5'-monophosphate (AMP)-induced bronchoconstriction in asthma

Adenosine, and its nucleotide, adenosine 5'-monophosphate (AMP), cause bronchoconstriction when inhaled by asthmatic and atopic, non-asthmatic subjects. This thesis describes a series of investigations into the mechanism whereby this effect is produced. Three drugs with mast cell membrane stabilising activity, sodium cromoglycate, nedocromil sodium and salbutamol, were found to displace the AMP dose-response curve to the right by 9.6, 22.2 and 26.6-fold respectively in asthmatic subjects. The potent, selective histamine-H1-receptor antagonist terfenadine produced a 16.2-fold rightward displacement of the AMP concentration-response curve in atopic asthmatic subjects, and inhibited the AMP FEV1-time response curve in non-atopic asthmatics by 80.8%. In this latter study, increasing the dose of terfenadine failed to increase the inhibition of the AMP response. In atopic non-asthmatic subjects, bronchoconstriction provoked by AMP and allergen was associated with approximately 2 and 2.5-fold increases respectively in venous plasma histamine concentrations. Bronchoprovocation with AMP did not provoke a late-asthmatic response or an increase in non-specific airways hyperresponsiveness. The cyclooxygenase inhibitor flurbiprofen inhibited the AMP response by 31.9% when expressed in terms of the area under the FEV1-time response curve, but failed to increase the degree of protection provided by terfenadine. Induction of tachyphylaxis to AMP potentiated rather than inhibited the subsequent allergen-provoked early asthmatic reaction. These studies suggest a central role for mast cell histamine release in mediating the AMP response, and probably a smaller contribution from newly generated mediators, notably prostanoids. The possible role of C-fibre neural reflexes is discussed. Bronchoprovocation with AMP may therefore reflect both non-specific airways hyperresponsiveness and the degree of immunological activation of bronchial mast cells.

University of Southampton
Phillips, Gerrard David
Phillips, Gerrard David

Phillips, Gerrard David (1990) The mechanism of adenosine 5'-monophosphate (AMP)-induced bronchoconstriction in asthma. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Adenosine, and its nucleotide, adenosine 5'-monophosphate (AMP), cause bronchoconstriction when inhaled by asthmatic and atopic, non-asthmatic subjects. This thesis describes a series of investigations into the mechanism whereby this effect is produced. Three drugs with mast cell membrane stabilising activity, sodium cromoglycate, nedocromil sodium and salbutamol, were found to displace the AMP dose-response curve to the right by 9.6, 22.2 and 26.6-fold respectively in asthmatic subjects. The potent, selective histamine-H1-receptor antagonist terfenadine produced a 16.2-fold rightward displacement of the AMP concentration-response curve in atopic asthmatic subjects, and inhibited the AMP FEV1-time response curve in non-atopic asthmatics by 80.8%. In this latter study, increasing the dose of terfenadine failed to increase the inhibition of the AMP response. In atopic non-asthmatic subjects, bronchoconstriction provoked by AMP and allergen was associated with approximately 2 and 2.5-fold increases respectively in venous plasma histamine concentrations. Bronchoprovocation with AMP did not provoke a late-asthmatic response or an increase in non-specific airways hyperresponsiveness. The cyclooxygenase inhibitor flurbiprofen inhibited the AMP response by 31.9% when expressed in terms of the area under the FEV1-time response curve, but failed to increase the degree of protection provided by terfenadine. Induction of tachyphylaxis to AMP potentiated rather than inhibited the subsequent allergen-provoked early asthmatic reaction. These studies suggest a central role for mast cell histamine release in mediating the AMP response, and probably a smaller contribution from newly generated mediators, notably prostanoids. The possible role of C-fibre neural reflexes is discussed. Bronchoprovocation with AMP may therefore reflect both non-specific airways hyperresponsiveness and the degree of immunological activation of bronchial mast cells.

This record has no associated files available for download.

More information

Published date: 1990

Identifiers

Local EPrints ID: 462049
URI: http://eprints.soton.ac.uk/id/eprint/462049
PURE UUID: 88987dfa-046c-446a-ba10-cc816c82211a

Catalogue record

Date deposited: 04 Jul 2022 19:00
Last modified: 04 Jul 2022 19:00

Export record

Contributors

Author: Gerrard David Phillips

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×